• Home
  • Anti-CD3 therapy promotes tolerance by selectively depleting pathogenic cells while preserving regulatory T cells.

Anti-CD3 therapy promotes tolerance by selectively depleting pathogenic cells while preserving regulatory T cells.

Author List
Penaranda C, Tang Q, Bluestone JA
Publication
Journal of immunology (Baltimore, Md. : 1950)
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1485487
Publication Year
2011
PubMed ID
21742976
Publication Title
Penaranda C, Tang Q, Bluestone JA. Anti-CD3 therapy promotes tolerance by selectively depleting pathogenic cells while preserving regulatory T cells. J Immunol. 2011 Aug 15; 187(4):2015-22.